Favorable government regulations and increasing outsourcing of pharmaceutical production to the APAC region is now driving the growth of chiral technology markets. The global market of chiral technology which was $4.75 billion in 2010 is projected to grow to $5.83 billion.

Pharmaceutical companies have been facing immense pressure on regulatory, pricing and market fronts and one of the key strategic pursuits they have been focusing on is identification, evaluation and leveraging the power of chiral technologies and enabling tools.

New advances in combinatorial and biocatalysis; asymmetric technologies; chiral separation technologies; design of chiral kit box complemented by adjacent technologies like genomics, gene shuffling technologies etc., have opened up new vistas for the industry to explore. Advances in molecular biology mean that drug discovery no longer relies on serendipity and drug design is now a clearly defined process.

Chiral India 2018, “The business of chirality: Contemporary and complementary technologies” will highlight the latest advances in chiral drug development and also explore many dimensions of contemporary chiral systems and complementary technologies for new drug design and development. In an attempt to highlight the power of chirality it will also highlight how chiral chemistry and tools are shaping new crop protection actives and advanced materials.